Product Code: PM4095
The global AI in pathology market size is expected to reach USD 89.71 million by 2032, according to a new study by Polaris Market Research. The report "AI in pathology Market Share, Size, Trends, Industry Analysis Report, By Component (Software, Scanners); By Neural Network; By Application; By End User; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
Initially, pathologists are used to examine pathology slides using microscopes. Visual observation and subjective interpretation have become ineffective in preventing intra- and interobserver disagreement. This facilitated the use of artificial intelligence in pathology, as automated approaches will improve the speed and accuracy of results, primarily through digital imaging. A recent study published in PubMed Central in 2022 evaluated the application of AI in pathology, along with trends and challenges.
The rising use of AI in computer applications is gaining traction among pathologists. The evolution of artificial intelligence, along with deep learning, is enabling image-based diagnosis with a background in digital pathology. Furthermore, the use of artificial intelligence by pathologists will save time and reduce errors, driving its use primarily in laboratories with more cases in the coming years.
The growing adoption of digital pathology laboratories at the global level is driving the use of artificial intelligence in the various tasks in pathology. A study published in 2023 focused on reviewing the digitalization of pathology labs. It revealed the benefits of digitalization, including lower reading time for cases and the need for second opinions. Digital pathology makes the diagnosis process faster and more efficient as it uses machine learning and artificial intelligence for the identification of diseases, symptoms, and ailments. This will enable scientists and doctors to choose the best treatment options, resulting in better patient outcomes.
As researchers come forward to check the reliability of artificial intelligence in pathology, there will be a rise in awareness about it among doctors, which may increase the adoption rate in the next few years.
AI in Pathology Market Report Highlights
The software segment is anticipated to witness the highest growth in the coming years due to advanced algorithms and improved diagnostics.
Conventional neural network segment accounted for the largest market share owing to the application of AI in image analysis.
The drug discovery segment is projected to experience a larger revenue share due to its ability to provide personalized medication.
Hospitals and reference laboratory segments are expected to witness significant growth owing to the prevalence of a higher caseload related to pathology.
Asia Pacific is projected to register the largest growth rate in the study period owing to the growing healthcare AI market.
The global players include: 4D Path, Aiforia Technologies, Aiosyn, Akoya Biosciences, deepPath, Deep Bio, Hologic, Ibex Medical Analytics & Indica Labs.
Polaris Market Research has segmented the AI in pathology market report based on component, neural network, application, end user and region:
AI in Pathology, Component Outlook (Revenue - USD Million, 2019 - 2032)
AI in Pathology, Neural Network Outlook (Revenue - USD Million, 2019 - 2032)
- Generative adversarial networks (GANS)
- Convolutional neural networks (CNNs)
- Recurrent neural networks (RNNs)
- Others
AI in Pathology, Application Outlook (Revenue - USD Million, 2019 - 2032)
- Drug Discovery
- Disease Diagnosis & Prognosis
- Clinical Workflow
- Training & Education
AI in Pathology, End User Outlook (Revenue - USD Million, 2019 - 2032)
- Pharmaceutical & Biotechnology Companies
- Hospitals & Reference Laboratories
- Academic & Research Institutes
AI in Pathology, Regional Outlook (Revenue - USD Million, 2019 - 2032)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
- Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Malaysia
- Latin America
- Argentina
- Brazil
- Mexico
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
3. Research Methodology
- 3.1. Overview
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global AI in Pathology Market Insights
- 4.1. AI in Pathology - Industry Snapshot
- 4.2. AI in Pathology Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. The global spread of diseases is driving the utilization of artificial intelligence
- 4.2.1.2. Precision medicine advancements through ai integration
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Integration challenges and workflow disruptions
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTLE Analysis
- 4.5. AI in Pathology Industry Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global AI in Pathology Market, by Neural Network
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
- 5.3. Generative adversarial networks (GANS)
- 5.3.1. Global AI in Pathology Market, by Generative adversarial networks (GANS), by Region, 2019-2032 (USD Million)
- 5.4. Convolutional neural networks (CNNs)
- 5.4.1. Global AI in Pathology Market, by Convolutional neural networks (CNNs), by Region, 2019-2032 (USD Million)
- 5.5. Recurrent neural networks (RNNs)
- 5.5.1. Global AI in Pathology Market, by Recurrent neural networks (RNNs), by Region, 2019-2032 (USD Million)
- 5.6. Others
- 5.6.1. Global AI in Pathology Market, by Others, by Region, 2019-2032 (USD Million)
6. Global AI in Pathology Market, by Component
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global AI in Pathology Market, by Component, 2019-2032 (USD Million)
- 6.3. Software
- 6.3.1. Global AI in Pathology Market, by Software, by Region, 2019-2032 (USD Million)
- 6.4. Scanners
- 6.4.1. Global AI in Pathology Market, by Scanners, by Region, 2019-2032 (USD Million)
7. Global AI in Pathology Market, by Application
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global AI in Pathology Market, by Application, 2019-2032 (USD Million)
- 7.3. Drug Discovery
- 7.3.1. Global AI in Pathology Market, by Drug Discovery, by Region, 2019-2032 (USD Million)
- 7.4. Diseax`se Diagnosis & Prognosis
- 7.4.1. Global AI in Pathology Market, by Diseax`se Diagnosis & Prognosis, by Region, 2019-2032 (USD Million)
- 7.5. Clinical Workflow
- 7.5.1. Global AI in Pathology Market, by Clinical Workflow, by Region, 2019-2032 (USD Million)
- 7.6. Training & Education
- 7.6.1. Global AI in Pathology Market, by Training & Education, by Region, 2019-2032 (USD Million)
8. Global AI in Pathology Market, by End Use
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Global AI in Pathology Market, by End Use, 2019-2032 (USD Million)
- 8.3. Pharmaceutical & Biotechnology Companies
- 8.3.1. Global AI in Pathology Market, by Pharmaceutical & Biotechnology Companies, by Region, 2019-2032 (USD Million)
- 8.4. Hospitals & Reference Laboratories
- 8.4.1. Global AI in Pathology Market, by Hospitals & Reference Laboratories, by Region, 2019-2032 (USD Million)
- 8.5. Academic & Research Institutes
- 8.5.1. Global AI in Pathology Market, by Academic & Research Institutes, by Region, 2019-2032 (USD Million)
9. Global AI in Pathology Market, by Geography
- 9.1. Key findings
- 9.2. Introduction
- 9.2.1. AI in Pathology Market Assessment, By Geography, 2019-2032 (USD Million)
- 9.3. AI in Pathology Market - North America
- 9.3.1. North America: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
- 9.3.2. North America: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
- 9.3.3. North America: AI in Pathology Market, by Component, 2019-2032 (USD Million)
- 9.3.4. North America: AI in Pathology Market, by Application, 2019-2032 (USD Million)
- 9.3.5. AI in Pathology Market - U.S.
- 9.3.5.1. U.S.: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
- 9.3.5.2. U.S.: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
- 9.3.5.3. U.S.: AI in Pathology Market, by Component, 2019-2032 (USD Million)
- 9.3.5.4. U.S.: AI in Pathology Market, by Application, 2019-2032 (USD Million)
- 9.3.6. AI in Pathology Market - Canada
- 9.3.6.1. Canada: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
- 9.3.6.2. Canada: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
- 9.3.6.3. Canada: AI in Pathology Market, by Component, 2019-2032 (USD Million)
- 9.3.6.4. Canada: AI in Pathology Market, by Application, 2019-2032 (USD Million)
- 9.4. AI in Pathology Market - Europe
- 9.4.1. Europe: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
- 9.4.2. Europe: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
- 9.4.3. Europe: AI in Pathology Market, by Component, 2019-2032 (USD Million)
- 9.4.4. Europe: AI in Pathology Market, by Application, 2019-2032 (USD Million)
- 9.4.5. AI in Pathology Market - UK
- 9.4.5.1. UK: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
- 9.4.5.2. UK: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
- 9.4.5.3. UK: AI in Pathology Market, by Component, 2019-2032 (USD Million)
- 9.4.5.4. UK: AI in Pathology Market, by Application, 2019-2032 (USD Million)
- 9.4.6. AI in Pathology Market - France
- 9.4.6.1. France: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
- 9.4.6.2. France: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
- 9.4.6.3. France: AI in Pathology Market, by Component, 2019-2032 (USD Million)
- 9.4.6.4. France: AI in Pathology Market, by Application, 2019-2032 (USD Million)
- 9.4.7. AI in Pathology Market - Germany
- 9.4.7.1. Germany: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
- 9.4.7.2. Germany: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
- 9.4.7.3. Germany: AI in Pathology Market, by Component, 2019-2032 (USD Million)
- 9.4.7.4. Germany: AI in Pathology Market, by Application, 2019-2032 (USD Million)
- 9.4.8. AI in Pathology Market - Italy
- 9.4.8.1. Italy: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
- 9.4.8.2. Italy: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
- 9.4.8.3. Italy: AI in Pathology Market, by Component, 2019-2032 (USD Million)
- 9.4.8.4. Italy: AI in Pathology Market, by Application, 2019-2032 (USD Million)
- 9.4.9. AI in Pathology Market - Spain
- 9.4.9.1. Spain: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
- 9.4.9.2. Spain: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
- 9.4.9.3. Spain: AI in Pathology Market, by Component, 2019-2032 (USD Million)
- 9.4.9.4. Spain: AI in Pathology Market, by Application, 2019-2032 (USD Million)
- 9.4.10. AI in Pathology Market - Netherlands
- 9.4.10.1. Netherlands: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
- 9.4.10.2. Netherlands: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
- 9.4.10.3. Netherlands: AI in Pathology Market, by Component, 2019-2032 (USD Million)
- 9.4.10.4. Netherlands: AI in Pathology Market, by Application, 2019-2032 (USD Million)
- 9.4.11. AI in Pathology Market - Russia
- 9.4.11.1. Russia: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
- 9.4.11.2. Russia.: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
- 9.4.11.3. Russia: AI in Pathology Market, by Component, 2019-2032 (USD Million)
- 9.4.11.4. Russia: AI in Pathology Market, by Application, 2019-2032 (USD Million)
- 9.5. AI in Pathology Market - Asia Pacific
- 9.5.1. Asia Pacific: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
- 9.5.2. Asia Pacific: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
- 9.5.3. Asia Pacific: AI in Pathology Market, by Component, 2019-2032 (USD Million)
- 9.5.4. Asia Pacific: AI in Pathology Market, by Application, 2019-2032 (USD Million)
- 9.5.5. AI in Pathology Market - China
- 9.5.5.1. China: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
- 9.5.5.2. China.: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
- 9.5.5.3. China: AI in Pathology Market, by Component, 2019-2032 (USD Million)
- 9.5.5.4. China: AI in Pathology Market, by Application, 2019-2032 (USD Million)
- 9.5.6. AI in Pathology Market - India
- 9.5.6.1. India: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
- 9.5.6.2. India.: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
- 9.5.6.3. India: AI in Pathology Market, by Component, 2019-2032 (USD Million)
- 9.5.6.4. India: AI in Pathology Market, by Application, 2019-2032 (USD Million)
- 9.5.7. AI in Pathology Market - Japan
- 9.5.7.1. Japan: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
- 9.5.7.2. Japan.: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
- 9.5.7.3. Japan: AI in Pathology Market, by Component, 2019-2032 (USD Million)
- 9.5.7.4. Japan: AI in Pathology Market, by Application, 2019-2032 (USD Million)
- 9.5.8. AI in Pathology Market - Malaysia
- 9.5.8.1. Malaysia: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
- 9.5.8.2. Malaysia.: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
- 9.5.8.3. Malaysia: AI in Pathology Market, by Component, 2019-2032 (USD Million)
- 9.5.8.4. Malaysia: AI in Pathology Market, by Application, 2019-2032 (USD Million)
- 9.5.9. AI in Pathology Market - Indonesia
- 9.5.9.1. Indonesia: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
- 9.5.9.2. Indonesia.: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
- 9.5.9.3. Indonesia: AI in Pathology Market, by Component, 2019-2032 (USD Million)
- 9.5.9.4. Indonesia: AI in Pathology Market, by Application, 2019-2032 (USD Million)
- 9.5.10. AI in Pathology Market - South Korea
- 9.5.10.1. South Korea: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
- 9.5.10.2. South Korea.: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
- 9.5.10.3. South Korea: AI in Pathology Market, by Component, 2019-2032 (USD Million)
- 9.5.10.4. South Korea: AI in Pathology Market, by Application, 2019-2032 (USD Million)
- 9.6. AI in Pathology Market - Middle East & Africa
- 9.6.1. Middle East & Africa: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
- 9.6.2. Middle East & Africa: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
- 9.6.3. Middle East & Africa: AI in Pathology Market, by Component, 2019-2032 (USD Million)
- 9.6.4. Middle East & Africa: AI in Pathology Market, by Application, 2019-2032 (USD Million)
- 9.6.5. AI in Pathology Market - Saudi Arabia
- 9.6.5.1. Saudi Arabia: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
- 9.6.5.2. Saudi Arabia: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
- 9.6.5.3. Saudi Arabia: AI in Pathology Market, by Component, 2019-2032 (USD Million)
- 9.6.5.4. Saudi Arabia: AI in Pathology Market, by Application, 2019-2032 (USD Million)
- 9.6.6. AI in Pathology Market - South Africa
- 9.6.6.1. South Africa: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
- 9.6.6.2. South Africa: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
- 9.6.6.3. South Africa: AI in Pathology Market, by Component, 2019-2032 (USD Million)
- 9.6.6.4. South Africa: AI in Pathology Market, by Application, 2019-2032 (USD Million)
- 9.6.7. AI in Pathology Market - Israel
- 9.6.7.1. Israel: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
- 9.6.7.2. Israel: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
- 9.6.7.3. Israel: AI in Pathology Market, by Component, 2019-2032 (USD Million)
- 9.6.7.4. Israel: AI in Pathology Market, by Application, 2019-2032 (USD Million)
- 9.6.8. AI in Pathology Market - UAE
- 9.6.8.1. UAE: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
- 9.6.8.2. UAE: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
- 9.6.8.3. UAE: AI in Pathology Market, by Component, 2019-2032 (USD Million)
- 9.6.8.4. UAE: AI in Pathology Market, by Application, 2019-2032 (USD Million)
- 9.7. AI in Pathology Market - Latin America
- 9.7.1. Latin America: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
- 9.7.2. Latin America: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
- 9.7.3. Latin America: AI in Pathology Market, by Component, 2019-2032 (USD Million)
- 9.7.4. Latin America: AI in Pathology Market, by Application, 2019-2032 (USD Million)
- 9.7.5. AI in Pathology Market - Mexico
- 9.7.5.1. Mexico: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
- 9.7.5.2. Mexico: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
- 9.7.5.3. Mexico: AI in Pathology Market, by Component, 2019-2032 (USD Million)
- 9.7.5.4. Mexico: AI in Pathology Market, by Application, 2019-2032 (USD Million)
- 9.7.6. AI in Pathology Market - Brazil
- 9.7.6.1. Brazil: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
- 9.7.6.2. Brazil: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
- 9.7.6.3. Brazil: AI in Pathology Market, by Component, 2019-2032 (USD Million)
- 9.7.6.4. Brazil: AI in Pathology Market, by Application, 2019-2032 (USD Million)
- 9.7.7. AI in Pathology Market - Argentina
- 9.7.7.1. Argentina: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
- 9.7.7.2. Argentina: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
- 9.7.7.3. Argentina: AI in Pathology Market, by Component, 2019-2032 (USD Million)
- 9.7.7.4. Argentina: AI in Pathology Market, by Application, 2019-2032 (USD Million)
10. Competitive Landscape
- 10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
- 10.2. Partnerships/Collaborations/Agreements/Exhibitions
11. Company Profiles
- 11.1. 4D Path
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
- 11.2. Aiforia Technologies
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
- 11.3. Aiosyn
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
- 11.4. Akoya Biosciences
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
- 11.5. deepPath
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
- 11.6. Deep Bio
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
- 11.7. DoMore Diagnostics AS
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
- 11.8. F. Hoffmann-La Roche
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
- 11.9. Hologic
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
- 11.10. Ibex Medical Analytics
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
- 11.11. Indica Labs
- 11.11.1. Company Overview
- 11.11.2. Financial Performance
- 11.11.3. Product Benchmarking
- 11.11.4. Recent Development
- 11.12. Konfoong Biotech International
- 11.12.1. Company Overview
- 11.12.2. Financial Performance
- 11.12.3. Product Benchmarking
- 11.12.4. Recent Development
- 11.13. Koninklijke Philips N.V.
- 11.13.1. Company Overview
- 11.13.2. Financial Performance
- 11.13.3. Product Benchmarking
- 11.13.4. Recent Development
- 11.14. Lumea
- 11.14.1. Company Overview
- 11.14.2. Financial Performance
- 11.14.3. Product Benchmarking
- 11.14.4. Recent Development
- 11.15. Mindpeak
- 11.15.1. Company Overview
- 11.15.2. Financial Performance
- 11.15.3. Product Benchmarking
- 11.15.4. Recent Development